GLAXOSMITHKLINE TO PAY $750 MILLION DOLLARS TO SETTLE ALLEGATIONS OF SELLING ADULTERATED DRUGS

The National Association of Medicaid Fraud Control Units announced on October 26, 2010, that the states and the federal government have reached an agreement in principle with the pharmaceutical manufacturer GlaxoSmithKline (GSK) to settle allegations that the company introduced adulterated drugs into interstate commerce.

Click here to get the file